Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system

por Kaineder, K, Birngruber, T, Rauter, G, Obermüller, B, Eichler, J, Münzker, J, Al-Zoughbi, W, Mautner, S I, Torekov, S S, Hartmann, B, Kotzbeck, P, Pieber, T R
Publicado 2017